Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma

Objectives. There have been advances in the identification and understanding of molecular subsets of lung cancer, defined by specific oncogenic aberrations. A number of actionable genetic alterations have been identified, such as the epidermal growth factor receptor (EGFR) mutation. We aimed to esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Rhian Siân, Smith, Christian, Edwards, Gwenllian, Butler, Rachel, Parry, Diane, Lester, Jason Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359447/
https://www.ncbi.nlm.nih.gov/pubmed/28367333
http://dx.doi.org/10.1155/2017/9614938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359447/
https://www.ncbi.nlm.nih.gov/pubmed/28367333
http://dx.doi.org/10.1155/2017/9614938

Ejemplares similares